Abstract: Detection of expression of the provided protein kinase in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. The encoded polypeptides further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: A system for profiling lymphoma is provided that is based on the identification of sets of genes, which are characterized in that changes in expression of each gene within a set of genes can be correlated to one or more features of a specific lymphoma. The lymphoma profiling system provides for sets of “lymphoma profiling” genes and further provides for combinations of polynucleotide probes derived from one or more of the lymphoma profiling sets. These combinations of polynucleotide probes can be provided in solution or as an array. The combination of probes and the arrays can be used for disease prognosis, diagnosis, staging or grading, treatment management, monitoring of disease progression, predicting disease outcome or complications, and the like.

Abstract: Detection of expression of the provided protein kinase in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. The encoded polypeptides further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: Methods for isolating CaMK-X1 genes are provided. The CaMK-X1nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.

Abstract: Detection of expression of the provided protein kinase in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis.

Abstract: Detection of expression of the provided protein kinase in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. The encoded polypeptides further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: Detection of DM-PK expression in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. DM-PK further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: Detection of SGK2 expression in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. SGK2 further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: Detection of GRK5 expression in cancers is useful as a diagnostic, for determining the effectiveness of drugs, and determining patient prognosis. GRK5 further provides a target for screening pharmaceutical agents effective in inhibiting the growth or metastasis of tumor cells.

Abstract: Methods for isolating CaMK-X1 genes are provided. The CaMK-X1nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.